首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >The synthesis of a benzamidine-containing NR2B-selective NMDA receptor ligand labelled with tritium or fluorine-18
【24h】

The synthesis of a benzamidine-containing NR2B-selective NMDA receptor ligand labelled with tritium or fluorine-18

机译:含tri或氟-18标记的含苯甲idine的NR2B选择性NMDA受体配体的合成

获取原文
获取原文并翻译 | 示例
           

摘要

A novel tritium or fiourine-18-labelled benzamidine-containing NR2B-selective NMDA receptor ligand has been synthesized. This compound was designed to contain the fluoromethoxy group to allow for the synthesis of a high specific activity, fluorine- 18-labelled PET tracer for imaging studies of the NR2B receptor. In addition to the fluorine-18-labelled compound, this compound was also tritium labelled. The tritiated ligand (11 Ci/mmol) was synthesized by a gas tritiation reaction of an aryl bromide precursor. The fluorine-18 ligand (2916 Ci/mmol), which was deuterated in the fluoromethoxy group to aid in metabolic stability, was synthesized by alkylating a phenolic precursor with [18F]fluoromethylbromide-d_2.
机译:合成了一种新型的tri或氟尿素18标记的含苯甲的NR2B选择性NMDA受体配体。设计该化合物包含氟甲氧基,以允许合成高比活度,用于NR2B受体成像研究的氟18标记的PET示踪剂。除了氟18标记的化合物外,该化合物还被tri标记。通过芳基溴化物前体的气体tri化反应合成化的配体(11 Ci / mmol)。通过用[18F]氟甲基溴化物-d_2烷基化酚类前体,合成了氟-18位配体(2916 Ci / mmol),在氟甲氧基中具有氘代以促进代谢稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号